Press releases
- Promore Pharma granted EU patent regarding treatment of chronic wounds
- The last clinic visit conducted in Promore Pharma’s phase II study of ensereptide
- Report from the Annual General Meeting of Promore Pharma AB held on 17 May 2022
- Promore Pharma — interim report January-March 2022
- Invitation to Conference Call regarding Promore Pharma’s Interim Report for the First Quarter 2022
Interim report January – March 2022
Promore Pharma AB (publ) published its interim report for the first quarter 2022 on 17 May 2022. The same day the company will host a webcast telephone conference at 16.00 CET, with President and CEO Jonas Ekblom and CFO Erik Magnusson, where an update for the quarter and upcoming activities.
